Sponsoring the ESC 2023 Congress
Sponsoring the ESC 2023 Congress
OMRON Healthcare sponsors the ESC 2023 Congress
OMRON Healthcare Co., Ltd. August 23, 2023. OMRON Healthcare Co., Ltd. (Head Office: Muko, Kyoto, President & CEO: Ayumu Okada, hereinafter referred to as the Company) announced the official sponsorship of European Society of Cardiology 2023 (hereinafter referred to as ESC Congress 2023) via OMRON Healthcare Europe B.V., OMRON Healthcare’s sales and marketing headquarter in Europe.
The annual congress of ESC 2023, the world’s largest congress on cardiovascular diseases will be held from August 25th to 28th, 2023 at the RAI in Amsterdam.
OMRON has been a partner for several years and at this year’s satellite symposium, the company will introduce the correlation between hypertension and atrial fibrillation, which is known to cause cardiogenic embolism. At the booth, a set of innovative devices and services available in Europe will be showcased.
Under the theme of “Revealing asymptomatic Atrial Fibrillation and hypertension in the fight against stroke,” the satellite sympodium will be chaired by Professor Faizel Osman of the Warwick Medical School and discuss blood pressure control and early detection of atrial fibrillation. The sympodium also introduces the latest study on detecting atrial fibrillation recurrence after ablation at home and a technique of diagnosing atrial fibrillation in 30 seconds and its advantages.
At the booth, the Company will present a set of innovative devices and services including Complete™, the upper-arm blood pressure monitor with built-in ECG technology that can record ECG while monitoring blood pressure, and a portable ECG device that allows users record an electro-cardiogram whenever they feel unwell. Viso, an OMRON Healthcare remote patient monitoring service, will also be showcased at the booth. Viso is a service, currently available in the U.K., that allows patients to share vital data measured at home with their doctors in real time, enabling doctors to intervene the hypertension management appropriately based on the patient's condition.
Aiming for zero cerebro-cardiovascular events, the Company has been working on advancing the ways of hypertension treatment in collaboration with healthcare professionals and researchers. The company will continue to promote academic activities globally, develop devices and services, and contribute to empowering people worldwide to live life to the fullest.
ESC Congress 2023 Event Outline
Title: European Society of Cardiology 2023
Date: 25-28 August 2023 (CEST)
Venue: RAI Amsterdam
Official website: ESC Congress 2023 (escardio.org)
Date & time: 10.15 - 11.00 on Sunday, 27 August 2023 (CEST)
Room: Luxembourg lecture room
Theme: Revealing asymptomatic Atrial Fibrillation and hypertension in the fight against stroke
Chair: Prof. Faizel Osman (Consultant Cardiologist / Electrophysiologist, University Hospital Coventry, UK, Honorary Professor of Cardiology, Warwick Medical School)
Theme: How blood pressure control and early detection of atrial fibrillation can prevent strokes
Speaker: Prof. Gerhard Hindricks (Professor of cardiology at the University of Leipzig, Leipzig, Germany.)
Theme: Detecting atrial fibrillation recurrence after ablation at home
Speaker: Assoc. Prof. Keitaro Senoo (Senior lecturer at Kyoto Prefectural University of Medicine.)
Theme: Diagnosing atrial fibrillation in 30 seconds and its advantages
Speaker: Prof. Faizel Osman
Public Relations Department
OMRON Healthcare Co., Ltd.
Address: 53 Kunotsubo, Terado-cho, Muko City, Kyoto 617-0002, Japan